Home
/ Sernova
/ Competitors

Sernova Competitors and Similar CompaniesClear all

Sernova's competitors and similar companies include InGeneron, SANUWAVE Health, Metavention and Admetsys.

	Sernova Sernova Biotherapeutics (formerly Sernova Corp.) is a regenerative medicine technology company developing products for the treatment of chronic diseases such as diabetes and hemophilia.	InGeneron InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells.	SANUWAVE Health SANUWAVE Health is a company that specializes in treating diabetic foot ulcers.	Metavention Metavention is a medical device company developing treatments for metabolic diseases.	Admetsys Admetsys is a biomedical technology company that develops a pancreas system for use in hospital and surgical care.
Founding Date	Founding Date 2006	Founding Date 2006	Founding Date 2005	Founding Date 2012	Founding Date 2010
Type	Type Public	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech diabetes medical devices medtech	Tags Manufacturing & Industrial biotech healthtech medical devices pharma therapy	Tags Healthcare biotech diabetes medical devices medtech rehabilitation	Tags Healthcare biotech diabetes medical devices medtech therapy	Tags Healthcare biotech diabetes medical devices medtech
Locations	Locations London, CA HQ	Locations Houston, US HQ München, DE	Locations Suwanee, US HQ Eden Prairie, US Madison, US	Locations Maple Grove, US HQ	Locations HQ
Employees	Employees N/A	Employees 16	Employees 1413% decrease	Employees 6	Employees 3
Valuation ($)	Valuation ($) 318.3 m	Valuation ($) N/A	Valuation ($) 22.4 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $44.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $10.1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $34m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($32.2m) (FY, 2024)	Net income N/A	Net income $11.8m (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 23m (almost 7 years ago)	Latest funding round N/A	Latest funding round $ 65m (over 8 years ago)	Latest funding round $ 35k (about 8 years ago)
Total funding raised	Total funding raised $ 6.3m	Total funding raised $ 47.5m	Total funding raised $ 12.1m	Total funding raised $ 65m	Total funding raised $ 35k